Just say no: Physician regulators warn against co-signing Ozempic prescriptions
Prescribers who co-sign, counter-sign or rewrite a semaglutide prescription for patients they haven’t seen or assessed would be considered in breach of professional standards, say two provincial regulators.
Register for free access or login.
Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.